.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
McKesson
Baxter
Healthtrust
Queensland Health
Medtronic
Chubb
Farmers Insurance
US Department of Justice

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,485,748

« Back to Dashboard

Which drugs does patent 6,485,748 protect, and when does it expire?


Patent 6,485,748 protects ALTOPREV and is included in one NDA.

Summary for Patent: 6,485,748

Title: Once daily pharmaceutical tablet having a unitary core
Abstract:A controlled release tablet is disclosed which comprises: (a) a homogeneous compressed core which comprises: (i) a medicament which is very slightly soluble to practically insoluble in water at 25.degree. C.; (ii) a water soluble osmotic compound (iii) one or more osmotic polymers; and (b) a membrane coating which completely covers said core tablet which comprises a mixture of a: (i) a water insoluble pharmaceutically acceptable polymer; and (ii) a pH dependent polymer such as an enteric coating polymer, the weight ratio of the pH dependent polymer to the water insoluble pharmaceutically acceptable polymer being 0.1:1 to 0.75:1. A controlled release tablet which comprises: (a) a medicament (a) a homogeneous compressed core which comprises: (i) a medicament; (ii) a water soluble osmotic compound (iii) one or more osmotic polymers; and (b) a membrane coating which completely covers said core tablet which comprises a mixture of: (i) a water insoluble pharmaceutically acceptable polymer; and (ii) an enteric polymer.
Inventor(s): Chen; Chih-Ming (Davie, FL), Chou; Joseph C. H. (Coral Springs, FL)
Assignee: Andrx Pharmaceuticals, Inc. (Davie, FL)
Application Number:08/990,129
Patent Claim Types:
see list of patent claims
Compound; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-001Jun 26, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-002Jun 26, 2002RXYesNo► Subscribe► SubscribeY► Subscribe
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-003Jun 26, 2002RXYesNo► Subscribe► SubscribeY► Subscribe
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-004Jun 26, 2002RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
US Department of Justice
Cipla
Dow
Mallinckrodt
Argus Health
Covington
Deloitte
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot